Michael V. Knopp MD, PhD

Michael V. Knopp MD, PhD
ProfessorCollege of Medicineknopp.16@osu.edu
430 Twelfth Avenue, 395 West 395 W 12th Avenue Columbus Ohio 43210
Phone:614-293-9998Alternate Phone:614-293-9227Fax: 614-293-9275
  • Experimental Therapeutics

General Research Interest

Oncological imaging for detection of disease characterization, staging, therapy planning and response assessment; imaging-based assessment of neoangiogenesis; imaging biomarker; semi-quantitative imaging

Research Description

The broad research activities focus on imaging biomarker for disease characterization and response assessment, imaging technology development and validation, imaging biomarker development and validation.

Transinstitutional Work

The research projects are consolidated under the Wright Center of Innovation in Biomedical Imaging which is a unique trans-institutional, interdisciplinary, academia/industry imaging technology development service and commercialization environment. Collaboration in all areas of health and biological sciences and engineering, arts and sciences and business are ongoing.

Current Publications

  • Knopp MVImproving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Invest Radiol 3/14/2014
  • Shapiro CLPhase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer.Clin Breast Cancer 2/20/2014
  • Povoski SP, Hall NC, Murrey DA Jr, Sharp DS, Hitchcock CL, Mojzisik CM, Bahnson EE, Knopp MV, Martin EW Jr, Bahnson RRMultimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.Surg Innov 20(1) 59-69 2/1/2013
  • Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O'Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie MFuture vision for the quality assurance of oncology clinical trials.Front Oncol 3 31 1/1/2013
  • Martin LK, Grecula J, Jia G, Wei L, Yang X, Otterson GA, Wu X, Harper E, Kefauver C, Zhou BS, Yen Y, Bloomston M, Knopp M, Ivy SP, Grever M, Bekaii-Saab TA dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer.Int J Radiat Oncol Biol Phys 84(4) e475-81 11/15/2012
  • Yang X, Mrozek E, Lustberg M, Jia G, Sammet S, Sammet C, Shapiro C, Knopp MVMicrocirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.Magn Reson Imaging 30(8) 1059-67 10/1/2012
  • Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, Knopp MV, Yuh WTCharacterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Int J Radiat Oncol Biol Phys 83(3) 972-9 7/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu